Mourad Wahba

Newcastle Upon Tyne, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis.

The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis.

Journal: Journal of affective disorders

Published: December 24, 2025

Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].

Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].

Journal: Journal of affective disorders

Published: October 11, 2025

Pramipexole augmentation for the acute phase of treatment-resistant, unipolar depression: a placebo-controlled, double-blind, randomised trial in the UK.

Pramipexole augmentation for the acute phase of treatment-resistant, unipolar depression: a placebo-controlled, double-blind, randomised trial in the UK.

Journal: The lancet. Psychiatry

Published: April 11, 2025

Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: case report and thematic analysis of one participant's experience.

Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: case report and thematic analysis of one participant's experience.

Journal: BJPsych open

Published: December 10, 2024

The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.

The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.

Journal: Journal of affective disorders

Published: August 01, 2024

Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.

Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.

Journal: Journal of affective disorders

Published: December 16, 2022

Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.

Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.

Journal: The New England journal of medicine

Published: November 02, 2022

Will psilocybin lose its magic in the clinical setting?

Will psilocybin lose its magic in the clinical setting?

Journal: Therapeutic advances in psychopharmacology

Published: November 19, 2021

Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021.

Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021.

Journal: BMC nephrology

Published: April 14, 2021

Authors' reply.

Authors' reply.

Journal: The British journal of psychiatry : the journal of mental science

Published: August 10, 2019

Showing 1-10 of 10

Last Updated: 09/26/2026